Sudeep Pharma IPO Allotment Is Out As Retail Interest Hits 93 Times Subscription
The allotment for the Sudeep Pharma IPO has been completed on November 26, and many investors are checking their status this morning. The demand for this issue was very high, and the total subscription reached 93.71 times. This made the allotment feel like a pure luck event for most retail applicants. Many investors are now looking at the status page to see if they received even one lot before the shares list on November 28.
The company raised ₹895 crore, with a part of the money coming in as fresh funds of ₹95 crore. The price band was set between ₹563 to ₹593. The minimum application required only 25 shares, which made it easy for retail investors to participate.
Sudeep Pharma works in specialty minerals used in medicine, baby food, supplements, and other health products. It exports 70 percent of its products and has maintained a debt-free position. The fast growth and strong international business gave investors confidence. This combination pushed demand to a very high level.
The final numbers reflected how strong the demand was across all categories.
| Category | How Many Times Subscribed |
|---|---|
| Retail | 104.23 times |
| High Net-worth (NII) | 152.89 times |
| Big Institutions (QIB) | 66.32 times |
| Overall | 93.71 times |
For retail applicants, the chance of receiving one lot came down to around 1 out of 13. Many investors submitted applications from multiple family accounts to increase their chances.
Investors can check the status in a few quick steps. Each option works within a few seconds.
If your bank still shows the blocked amount and the status appears as allotted, then your shares will reach your demat account by tonight. If you did not get allotment, the refund will reflect today itself.
The Grey Market Premium this morning stands at ₹96. With this premium, the expected listing price is close to ₹689, which is around a 16 percent gain from the upper price band. The GMP had fallen earlier, but strong demand from retail and NII investors helped it move up again.
Market discussions show excitement among retail buyers. Some investors reported multiple successful lots from many applications. Others are already planning their strategy for the listing day and watching for early movements in the stock.
Shares will be credited to demat accounts by this evening. Refunds will also be processed today. Trading will begin on both exchanges at 10 AM tomorrow.
Some investors plan to hold their allotment for a longer period because the company operates in the pharma excipient and nutraceutical segment. These are stable areas with steady demand. The export business continues to grow, and the company is setting up a new facility. The balance sheet remains strong as the business has no major debt.
Investors who did not receive allotment can look forward to more pharma and specialty chemical IPOs that are expected in the coming weeks.
Share This Post